Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.

Saved in:
Bibliographic Details
Title: Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.
Authors: Mørk SK; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark sofie.kirial.moerk@regionh.dk., Skadborg SK; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Albieri B; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Draghi A; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Bol K; Medical Oncology, Radboudumc, Nijmegen, The Netherlands., Kadivar M; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Westergaard MCW; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Stoltenborg Granhøj J; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Borch A; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Petersen NV; Evaxion Biotech, Copenhagen, Denmark., Thuesen N; Evaxion Biotech, Copenhagen, Denmark., Rasmussen IS; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Andreasen LV; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Dohn RB; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Yde CW; Genomic Medicine, Rigshospitalet, Copenhagen, Denmark., Noergaard N; Department of Urology, Copenhagen University Hospital, Herlev, Denmark., Lorentzen T; Department of Gastroenterology, Copenhagen University Hospital, Herlev, Denmark., Soerensen AB; Evaxion Biotech, Copenhagen, Denmark., Kleine-Kohlbrecher D; Evaxion Biotech, Copenhagen, Denmark., Jespersen A; Evaxion Biotech, Copenhagen, Denmark., Christensen D; Center for Vaccine Research, Statens Serum Institut, Copenhagen, Denmark., Kringelum J; Evaxion Biotech, Copenhagen, Denmark., Donia M; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark., Hadrup SR; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Marie Svane I; Department of Oncology, Copenhagen University Hospital, National Center for Cancer Immune Therapy (CCIT-DK), Herlev, Denmark.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 May 23; Vol. 12 (5). Date of Electronic Publication: 2024 May 23.
Publication Type: Clinical Study; Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2024-008817